Dr. Vijay N Prabhu, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 105 S Bryant Ave, Suite 200, Edmond, OK 73034 Phone: 405-340-4937 Fax: 405-341-3078 |
News Archive
ViroPharma Incorporated today announced the presentation of two abstracts relating to Cinryze™ (C1 esterase inhibitor [human]) therapy at the First International Congress of the Southern European Allergy Society in Florence, Italy.
Researchers at National Jewish Health and dozens of leading institutions around the nation have proposed new criteria for diagnosing chronic obstructive pulmonary disease (COPD), the fourth leading cause of death in the United States.
New research shows that adults with systemic lupus erythematosus, who receive trimethoprim-sulfamethoxazole (TMP-SMX), a prophylactic therapy to help prevent pneumocystis pneumonia, are at high risk for adverse reactions to the drug, particularly if they are also positive for anti-Smith (anti-Sm) antibodies.
Insomnia and obstructive sleep apnea have increased dramatically among active-duty military members over a 14-year period, 2005 through 2019.
At a time when lipid management in the United States is undergoing transition in response to new guideline recommendations and expanding lipid-lowering therapy options, the Duke Clinical Research Institute (DCRI) today announced a new study to better understand contemporary lipid management as well as the beliefs and attitudes of patient and providers regarding cholesterol, cardiovascular risk assessment, and options for lipid treatments.
› Verified 2 days ago